What Problem With Emerging Markets Trial Data?
08:52 EDT 19 Jul 2012 | Pharmalot
The ongoing debate over the growing use of clinical trials in so-called emerging markets has been the proverbial thorn in the side of clinical research organizations. The cost of running these trials in such countries can cost less than in the US, fo..
Original Article: What Problem With Emerging Markets Trial Data?
More From BioPortfolio on "What Problem With Emerging Markets Trial Data?"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
